Barclays PLC Moderna, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Barclays PLC holds 1,532,812 shares of MRNA stock, worth $60.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,532,812

Previous 20,000 7564.06%

Holding current value

$60.4 Million

Previous $1.34 Million 7561.71%

% of portfolio

0.03%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$63.64 - $125.14 $12.3 Million - $24.2 Million	193,059 Added 14.41%	1,532,812 $102 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $14.9 Million - $24.5 Million	146,856 Added 12.31%	1,339,753 $159 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $7.23 Million - $9.78 Million	84,733 Added 7.65%	1,192,897 $127 Million
Q4 2023 Feb 15, 2024	BUY	$69.51 - $104.43 $11.3 Million - $17 Million	163,264 Added 17.28%	1,108,164 $110 Million
Q3 2023 Nov 07, 2023	BUY	$96.41 - $126.61 $3.28 Million - $4.31 Million	34,008 Added 3.73%	944,900 $97.6 Million
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $30.4 Million - $41.1 Million	256,295 Added 39.15%	910,892 $111 Million
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $110 Million - $160 Million	-813,653 Reduced 55.42%	654,597 $101 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $14.3 Million - $25.3 Million	-120,454 Reduced 7.58%	1,468,250 $264 Million
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $47.2 Million - $77.6 Million	399,454 Added 33.59%	1,588,704 $188 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $14.6 Million - $22.1 Million	-124,917 Reduced 9.51%	1,189,250 $170 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $251 Million - $467 Million	-1,987,952 Reduced 60.2%	1,314,167 $226 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $462 Million - $754 Million	2,047,118 Added 163.12%	3,302,119 $839 Million
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $146 Million - $318 Million	657,299 Added 109.97%	1,255,001 $483 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $24 Million - $43.5 Million	185,034 Added 44.84%	597,702 $140 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $20.8 Million - $35.5 Million	-190,618 Reduced 31.6%	412,668 $54 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $12.4 Million - $32.2 Million	-189,310 Reduced 23.88%	603,286 $63 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $19.4 Million - $33.8 Million	356,811 Added 81.88%	792,596 $56.1 Million
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $9.57 Million - $25.8 Million	322,685 Added 285.31%	435,785 $28 Million
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $1.68 Million - $2.98 Million	94,258 Added 500.25%	113,100 $3.39 Million
Q4 2019 Feb 10, 2020	SELL	$13.93 - $21.28 $127,640 - $194,988	-9,163 Reduced 32.72%	18,842 $369,000
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $173,172 - $255,238	-14,125 Reduced 33.53%	28,005 $446,000
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $420,603 - $870,066	-30,701 Reduced 42.15%	42,130 $617,000
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $1.05 Million - $1.73 Million	72,831 New	72,831 $1.48 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account